Navigation Links
Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
Date:6/19/2013

zing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medical healthcare needs; and to identify promising product candidates based on scientific development expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development with partners when and where appropriate.

Presently, Pharmacyclics has two product candidates in clinical development and several preclinical molecules in lead optimization. The Company is committed to high standards of ethics, scientific rigor, and operational efficiency as it moves each of these programs to viable commercialization.

The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements, including our expected liquidity position and timing of the receipt of certain milestone payments, and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in thi
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
2. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
3. Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma
4. Ibrutinib Expanded Access Program Open to Eligible U.S. Patients with Relapsed or Refractory Mantle Cell Lymphoma
5. Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid and Sustainable Disease Control Irrespective of Age or High Risk Prognostic Factor
6. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
7. Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
8. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
9. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
10. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
11. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015   Temptime Corporation , the ... care industry, announced today that its board of directors ... to chief executive officer.  Mr. Van den Hooff ... 2011. "Renaat deeply values Temptime,s mission of ... of expanding Temptime,s products and services to organizations that ...
(Date:5/5/2015)... --  InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the ... it will release its full financial results for the first ... before the open, followed by a conference call at ... outlook. Participants should call (888) 243-4451 ( ... the InspireMD call. A live webcast of the call will ...
(Date:5/5/2015)... LINCOLNSHIRE, Ill. , May 5, 2015 /PRNewswire/ ... medical diagnostic testing equipment and information systems technology, ... laboratory information systems company. This partnership allows Sysmex ... software and interfacing solution for physician offices and ... analyzer directly to Electronic Medical Record (EMR) systems. ...
Breaking Medicine Technology:Temptime President Renaat Van den Hooff Promoted to CEO 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 2Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 3
... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA ), ... the appointment of Mr. Kenneth Lee as a director to ... to replace Mr. Xianping Wang who resigned from the Board ... a Principal at SAIF Partners, a leading growth capital fund ...
... CHAPEL HILL, N.C., May 31, 2011 Cempra Pharmaceuticals ... executive officer, will present at the Jefferies 2011 Global ... at the Grand Hyatt in New York City.  Dr. ... leading antibiotic clinical programs, solithromycin for community-acquired bacterial pneumonia ...
Cached Medicine Technology:Sinovac Appoints Kenneth Lee to Board of Directors 2
(Date:5/5/2015)... The 2015 Crystal Ball, hosted by the Hepatitis ... outreach and patient advocacy programs. The gala evening included dancing, ... hundreds of supporters. , The 2015 gala was dedicated to ... virus (HBV) by Dr. Baruch S. Blumberg, who passed away ... for his discovery of the virus in 1976. He and ...
(Date:5/5/2015)... Jacksonville, Fla. (PRWEB) May 05, 2015 ... from the Commission on Cancer (CoC) of the American ... a cancer program must meet more than 30 Commission ... years through a survey process, and maintain levels of ... , When patients choose to seek care locally ...
(Date:5/5/2015)... " QuickPick Travel ” was featured on NewsWatch ... look small, medium, and large businesses making an impact in ... business expert, conducted the business review and shared with viewers ... three weeks of vacation for free. , Vacations are a ... the world. And when people are preparing for vacations, they’re ...
(Date:5/5/2015)... York, NY (PRWEB) May 05, 2015 ... Platform that enables businesses to deploy Mobile Engagement Campaigns ... Constant Contact . ProTexting clients can now leverage the ... reach by collecting and syncing subscribers’ e-mail addresses into ... says “We have recognized that the growing trend of ...
(Date:5/5/2015)... Orange, New Jersey (PRWEB) May 05, 2015 ... system, today announced the launch of a new healthy ... Talbot, a season two semi-finalist on Bravo’s Top Chef, ... dishes that promote wellness and healthy living. In ... an enhanced Wellness Website and the videos will be ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 2Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 3
... Designed to Reduce the Risk of a Subsequent Stroke, ... today,announced the launch of The TIA (Transient Ischemic Attack) ... the first of its kind in,Central Texas -- in ... stroke after TIA., A TIA is a "warning ...
... NET SatisFAXtion recognized for highly reliable and secure VoIP fax solutions ... ... (Vocus) October 27, 2008 -- FaxBack® , the leading provider ... INTERNET TELEPHONY® Magazine - the VoIP authority since 1998 - has ...
... - Special Needs Plan focuses on added benefits ... for Medicare beneficiaries with chronic health conditions -, ... the upcoming,Medicare annual enrollment period which begins November ... its 2009 Special Needs Plan,(SNP) offerings for chronically ...
... to $4.7 million in the ... revenue of $4.3 million in the first quarter of fiscal 2009, a 26% ... year-over-year increase, - Strong sales to pharmaceutical manufacturers and retail market customers ... drove growth in the first quarter - ...
... Dietitian Kris Clark, Ph.D., offers easy tips ... and fun - Halloween!, WASHINGTON, Oct. 27 If ... aged five to thirteen years, are,poised to don costumes to ... on sweet treats, registered dietitian Kris Clark,Ph.D., of Pennsylvania State ...
... Business Impact for the development of an automated process to dramatically ... , ... Irvine, CA (Vocus) October 27, 2008 -- When ... , , ,LifeMasters Supported SelfCare, Inc. is strengthening its health improvement ...
Cached Medicine News:Health News:St. David's HealthCare Launches The TIA Center for Stroke Prevention at St. David's Medical Center 2Health News:St. David's HealthCare Launches The TIA Center for Stroke Prevention at St. David's Medical Center 3Health News:FaxBack Wins the 2008 Internet Telephony Excellence Award 2Health News:FaxBack Wins the 2008 Internet Telephony Excellence Award 3Health News:Care Improvement Plus Launches 2009 Benefits in Georgia 2Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 2Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 3Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 4Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 5Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 6Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 7Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 8Health News:No Trick to Halloween Sweet Treats 2Health News:No Trick to Halloween Sweet Treats 3Health News:LifeMasters Receives 2008 Vision Award for Business Impact 2Health News:LifeMasters Receives 2008 Vision Award for Business Impact 3
For the quantitative in vitro determination of Aspartate Aminotransferase (AST) in serum and plasma....
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
This is an Immunological assay intended for the quantitative in vitro determination of haemoglobin A1c (HbA1c) in whole blood....
Medicine Products: